Fosamax Femur Fracture Risk Examined in Medical Journal
A new case report about an unusual Fosamax femur fracture risk indicates that a bone development imbalance may be linked to long-term use of the osteoporosis drug.
A new case report about an unusual Fosamax femur fracture risk indicates that a bone development imbalance may be linked to long-term use of the osteoporosis drug.
A federal judge in New York has rejected a motion filed by Merck & Co. to dismiss 24 Fosamax lawsuits that claimed side effects of their osteoporosis drug caused severe…
According to a pretrial order, Merck & Co. will not face the possibility of punitive damages in the first Fosamax trial scheduled to begin next month in New York. The…
According to an official from the FDA, Fosamax side effects may increase the risk of esophageal cancer. A number of cases have been reported involving individuals who developed esophageal tumors…
The FDA issued a statement Wednesday indicating that their safety review of bone drugs known as bisphosphonates, indicates that the medications have no association with an increased rate of atrial…
According to a study presented this week at the 74th annual conference of the American College of Chest Physicians, the use of osteoporosis drugs Zometa and Fosamax increase the risk…